日本造血細胞移植学会雑誌
Online ISSN : 2186-5612
研究報告
Clinical characteristics of calcineurin inhibitor-induced pain syndrome (CIPS) after allogeneic hematopoietic stem cell transplantation
Noriko DokiKazuhiko KakihanaMasahiro AshizawaMasahiro OnodaChikako OhwadaSumiko KobayashiMoritaka GotohShin FujisawaShinichiro Okamotofor the Kanto Study Group for Cell Therapy
著者情報
ジャーナル フリー

2017 年 6 巻 2 号 p. 115-119

詳細
抄録

 Calcineurin inhibitor (CI)-induced pain syndrome (CIPS) is a rare complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, because of its rarity, the optimal management of this complication remains unknown.

 We analyzed the clinical features and treatment outcomes of the patients who developed CIPS after allo-HSCT. The study included patients who underwent allo-HSCT between January 2003 and December 2014 at the hospitals participating in the KSGCT. Sixteen patients developed CIPS. The most common symptom was leg pain, which was observed in 9 patients, followed by leg pain associated with pruritus in five, and pruritus only in two. The median time from allo-HSCT to CIPS was 16 days. CIPS occurred within 30 days of starting CIs in 14 patients (87.5%). CI was discontinued in four patients; the dose of CI was reduced in two patients, and seven patients were switched to another CI. The symptoms in all of those 13 patients with intervention resolved within 6 days from the onset of CIPS.

 The possibility of CIPS must be considered when patients who have undergone allo-HSCT develop intolerable leg pain and/or pruritus. Our findings suggest that withdrawal/dose reduction of the CI or substitution with another CI is an effective treatment for CIPS.

著者関連情報
© 2017 The Japan Society for Hematopoietic Stem Cell Transplantation
前の記事 次の記事
feedback
Top